What is the recommended approach when a CCDA contains conflicting medication data with the receiving chart?

• A. Initiate data reconciliation, verify with the source system, and annotate for clinician review; prefer the most recent authoritative data.
• B. Discard conflicting data and rely on the existing chart.
• C. Automatically overwrite receiving chart with CCDA data.
• D. Notify the patient and let them choose.

Answer: (A)

When a CCDA contains conflicting medication data with the receiving chart, the best approach is to reconcile the data by validating against the source system, annotating the reconciliation for clinician review, and preferring the most recent authoritative data. This process ensures the patient’s current medications are accurate, maintains an auditable trail of how the final list was determined, and involves clinicians when decisions could impact safety. Rushing to overwrite, discard data without verification, or delay clinician input can propagate outdated or incorrect information and increase risk. Notifying the patient without professional review doesn’t resolve the discrepancy in a way that keeps the chart trustworthy.